Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Wennberg L et al. |
Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection. |
1995 |
Transplant. Proc. |
pmid:8539967
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Felldin M et al. |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis. |
1995 |
Transplant. Proc. |
pmid:8540032
|
Bersztel A et al. |
Deoxyspergualin is synergistic with cyclosporin A, but not with FK506 in a rat heart allograft transplantation model. |
1995 |
Transplant. Proc. |
pmid:8540095
|
Jonas S et al. |
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. |
1995 |
Clin Transplant |
pmid:8541635
|
Andoh TF et al. |
Functional and structural characteristics of experimental FK 506 nephrotoxicity. |
1995 |
Clin. Exp. Pharmacol. Physiol. |
pmid:8542679
|
Monfar M et al. |
Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. |
1995 |
Mol. Cell. Biol. |
pmid:7528328
|
Echigo Y et al. |
Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. |
1995 |
Arch Surg |
pmid:7528496
|
Lemster BH et al. |
IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. |
1995 |
Clin. Exp. Immunol. |
pmid:7531627
|
Chaudhuri B et al. |
The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two-hybrid system, is disrupted by cyclosporin A and FK506. |
1995 |
FEBS Lett. |
pmid:7528690
|
Timerman AP et al. |
Characterization of an exchange reaction between soluble FKBP-12 and the FKBP.ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity. |
1995 |
J. Biol. Chem. |
pmid:7531689
|
Sandborn WJ et al. |
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue. |
1995 |
Hepatology |
pmid:7528712
|
Richter A et al. |
Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. |
1995 |
Biochem. Pharmacol. |
pmid:7531976
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Bierer BE |
Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin. |
1995 |
Proc. Assoc. Am. Physicians |
pmid:8630742
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Mueller AR et al. |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. |
1995 |
Transplant. Proc. |
pmid:7533359
|
Abouljoud MS et al. |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533360
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Mor E et al. |
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study. |
1995 |
Transplant. Proc. |
pmid:7533363
|
Hemenway CS et al. |
vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. |
1995 |
Genetics |
pmid:8582630
|
Senninger N et al. |
Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506. |
1995 |
Transplant. Proc. |
pmid:7533364
|
Gonschior AK et al. |
Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. |
1995 |
Ther Drug Monit |
pmid:8585114
|
Loss M et al. |
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. |
1995 |
Transplant. Proc. |
pmid:7533365
|
Büttemeyer R et al. |
Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression. |
1995 |
Ann Plast Surg |
pmid:8585683
|
Kawano K et al. |
Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. |
1995 |
Transplant. Proc. |
pmid:7533410
|
Charters AR et al. |
Developmental expression of FK506 binding proteins and calcineurin in rat brain. |
1995 |
Biochem. Soc. Trans. |
pmid:8566310
|
Tanabe M et al. |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. |
1995 |
Transplant. Proc. |
pmid:7533411
|
Abu-Elmagd K et al. |
The current status of hepatic transplantation at the University of Pittsburgh. |
1995 |
Clin Transpl |
pmid:8794262
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Shapiro R et al. |
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. |
1995 |
Clin Transpl |
pmid:8794266
|
Jiang H et al. |
Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533413
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Ochiai T et al. |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533419
|
Saito S et al. |
The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft. |
1995 |
Transplant. Proc. |
pmid:7533420
|
Tashiro H et al. |
Monitoring for engraftment of rat orthotopic liver transplantation by semiquantitative PCR. |
1995 |
Transplant. Proc. |
pmid:7533421
|
Shirakata Y et al. |
The minimum graft size for successful orthotopic partial liver transplantation in the canine model. |
1995 |
Transplant. Proc. |
pmid:7533422
|
Jusko WJ et al. |
Pharmacokinetics of tacrolimus in liver transplant patients. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7535213
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Bakhtiar R and Stearns RA |
Studies on non-covalent associations of immunosuppressive drugs with serum albumin using pneumatically assisted electrospray ionization mass spectrometry. |
1995 |
Rapid Commun. Mass Spectrom. |
pmid:7535601
|
Ikeda H and Fujiwara K |
Cyclosporin A and FK-506 in inhibition of rat Ito cell activation in vitro. |
1995 |
Hepatology |
pmid:7535735
|
Grimmond S et al. |
Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1. |
1995 |
Hum. Genet. |
pmid:7535744
|
Kanamaru A et al. |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. |
1995 |
Bone Marrow Transplant. |
pmid:7581086
|
Koehler MT et al. |
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:7581088
|
Reisman L et al. |
Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination. |
1995 |
Transpl. Immunol. |
pmid:7551978
|
Woo J et al. |
Effects of FK 506 on chimerism and the induction of donor-specific unresponsiveness following fully allogeneic bone marrow transplantation in mice. |
1995 |
Transpl. Immunol. |
pmid:7551985
|
Tanida I et al. |
Cooperation of calcineurin and vacuolar H(+)-ATPase in intracellular Ca2+ homeostasis of yeast cells. |
1995 |
J. Biol. Chem. |
pmid:7537264
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
Koch K et al. |
The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant. |
1995 |
J. Med. Chem. |
pmid:7537331
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Torii N et al. |
An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex. |
1995 |
Neurosci. Lett. |
pmid:7537357
|
Holmes JA and Twentyman PR |
The activity of deoxyspergualin in multidrug-resistant cells. |
1995 |
Cancer Chemother. Pharmacol. |
pmid:7554042
|
Miyazawa H et al. |
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. |
1995 |
Transplantation |
pmid:7537396
|
Elitsur Y et al. |
FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system. |
1995 |
Dig. Dis. Sci. |
pmid:7555446
|
Pockley AG et al. |
Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells. |
1995 |
Biochem. Soc. Trans. |
pmid:8654800
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Kobayashi I et al. |
Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. |
1995 |
Eur. J. Pediatr. |
pmid:7556338
|
Mañez R et al. |
Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation. |
1995 |
Transplantation |
pmid:7537400
|
Van Thiel DH et al. |
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7537444
|
Woodle ES et al. |
FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach. |
1995 |
Clin Transplant |
pmid:7537988
|
Mills RA et al. |
Topical FK-506 prevents experimental corneal allograft rejection. |
1995 |
Cornea |
pmid:7538061
|
Romero DF et al. |
Rapamycin: a bone sparing immunosuppressant? |
1995 |
J. Bone Miner. Res. |
pmid:7543725
|
Rebollo A et al. |
Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. |
1995 |
Cytokine |
pmid:7543780
|
Lam E et al. |
Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs. |
1995 |
Gene |
pmid:7543869
|
Minamoto A et al. |
Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty. |
1995 |
Jpn. J. Ophthalmol. |
pmid:7543958
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Nash RA et al. |
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. |
1995 |
Blood |
pmid:7540071
|
Ishikawa A et al. |
[A case of tacrolimus-induced glucose intolerance following renal allografting]. |
1995 |
Hinyokika Kiyo |
pmid:7544064
|
Bennett WM |
The nephrotoxicity of immunosuppressive drugs. |
1995 |
Clin. Nephrol. |
pmid:7540121
|
Lochmüller H et al. |
Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7544122
|
Moro A et al. |
Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. |
1995 |
EMBO J. |
pmid:7540135
|
Deschler DG et al. |
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. |
1995 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:7544136
|
Zweifach A and Lewis RS |
Slow calcium-dependent inactivation of depletion-activated calcium current. Store-dependent and -independent mechanisms. |
1995 |
J. Biol. Chem. |
pmid:7540169
|
Brand PL and Brus F |
Immunosuppressive drugs and hypertrophic cardiomyopathy. |
1995 |
Lancet |
pmid:7540240
|
Natazuka T et al. |
Immunosuppressive drugs and hypertrophic cardiomyopathy. |
1995 |
Lancet |
pmid:7540241
|
Dhawan A et al. |
Immunosuppressive drugs and hypertrophic cardiomyopathy. |
1995 |
Lancet |
pmid:7540242
|
Han CW et al. |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. |
1995 |
Bone Marrow Transplant. |
pmid:7545487
|
Hattori Y and Nakanishi N |
Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. |
1995 |
Cell. Immunol. |
pmid:7545550
|
Han JW et al. |
Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. |
1995 |
J. Biol. Chem. |
pmid:7545671
|
Ruff VA and Leach KL |
Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. |
1995 |
J. Biol. Chem. |
pmid:7545680
|
Shaw KT et al. |
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479966
|
Matsuo S and Okamoto K |
Enhancement of FK-506 activities by ganglioside (GM3) in vivo. |
1995 |
Life Sci. |
pmid:7545772
|
Annesley TM et al. |
Stability of tacrolimus (FK 506) and cyclosporin G in whole blood. |
1995 |
Ther Drug Monit |
pmid:7482690
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Lampen A et al. |
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. |
1995 |
Drug Metab. Dispos. |
pmid:8689938
|
Lake JR et al. |
The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial. |
1995 |
Transplantation |
pmid:7482713
|
Bolman RM |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients. |
1995 |
Ann. Thorac. Surg. |
pmid:7545888
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
Keenan RJ et al. |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. |
1995 |
Ann. Thorac. Surg. |
pmid:7545889
|
Okamoto M et al. |
In situ proliferating status of mononuclear cells in rat small bowel grafts. |
1995 |
Int J Exp Pathol |
pmid:7547442
|
Sakane T et al. |
[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions]. |
1995 |
Ryumachi |
pmid:8594659
|
Hammond TG and Kind CN |
Pancreatic and nephrotoxicity of immunomodulator compounds. |
1995 |
Toxicol. Lett. |
pmid:8597171
|